These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients. Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596 [TBL] [Abstract][Full Text] [Related]
6. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus. Schmitt V; Meuth AM; Amler S; Kuehn E; Haust M; Messer G; Bekou V; Sauerland C; Metze D; Köpcke W; Bonsmann G; Kuhn A Br J Dermatol; 2010 Jan; 162(1):64-73. PubMed ID: 19712116 [TBL] [Abstract][Full Text] [Related]
7. Classification of lupus erythematosus based upon Japanese patients. Tsuchida T Autoimmun Rev; 2009 May; 8(6):453-5. PubMed ID: 19162249 [TBL] [Abstract][Full Text] [Related]
9. Clinical course and prognosis of cutaneous lupus erythematosus. Tebbe B Clin Dermatol; 2004; 22(2):121-4. PubMed ID: 15234012 [TBL] [Abstract][Full Text] [Related]
10. The use of antibody to C5b-9 in the subclassification of lupus erythematosus. Magro CM; Crowson AN; Harrist TJ Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325 [TBL] [Abstract][Full Text] [Related]
11. The classification and diagnosis of cutaneous lupus erythematosus. Kuhn A; Landmann A J Autoimmun; 2014; 48-49():14-9. PubMed ID: 24486120 [TBL] [Abstract][Full Text] [Related]
12. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus. Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736 [TBL] [Abstract][Full Text] [Related]
13. Studies on criteria of the European Academy of Dermatology and Venerology for the classification of cutaneous lupus erythematosus. I. Selection of clinical groups and study factors. Beutner EH; Blaszczyk M; Jablonska S; Chorzelski TP; Kumar V; Wolska H Int J Dermatol; 1991 Jun; 30(6):411-7. PubMed ID: 1894405 [TBL] [Abstract][Full Text] [Related]
14. [Lupus erythematosus of the skin. An analysis of 97 patients]. Tebbe B; Orfanos CE Z Hautkr; 1987 Nov; 62(22):1563-72, 1577-8, 1583-4. PubMed ID: 3501642 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus. Järvinen TM; Hellquist A; Koskenmies S; Einarsdottir E; Koskinen LL; Jeskanen L; Berglind L; Panelius J; Hasan T; Ranki A; Kere J; Saarialho-Kere U Exp Dermatol; 2010 Feb; 19(2):123-31. PubMed ID: 19758313 [TBL] [Abstract][Full Text] [Related]
16. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459 [TBL] [Abstract][Full Text] [Related]
17. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Sontheimer RD; Thomas JR; Gilliam JN Arch Dermatol; 1979 Dec; 115(12):1409-15. PubMed ID: 533284 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus. Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363 [TBL] [Abstract][Full Text] [Related]
19. Drug-induced lupus: an update on its dermatologic aspects. Marzano AV; Vezzoli P; Crosti C Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393 [TBL] [Abstract][Full Text] [Related]